Order Article Reprints

Abdelrahim M, Al-Rawi H, Esmail A, Xu J, Umoru G, Ibnshamsah F, Abudayyeh A, Victor D, Saharia A, McMillan R, et al. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series. Current Oncology. 2022; 29(5):3585-3594. https://doi.org/10.3390/curroncol29050290

Abdelrahim, Maen, Hadeel Al-Rawi, Abdullah Esmail, Jiaqiong Xu, Godsfavour Umoru, Fahad Ibnshamsah, Ala Abudayyeh, David Victor, Ashish Saharia, Robert McMillan, and et al. 2022. "Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series" Current Oncology 29, no. 5: 3585-3594. https://doi.org/10.3390/curroncol29050290

Abdelrahim, M., Al-Rawi, H., Esmail, A., Xu, J., Umoru, G., Ibnshamsah, F., Abudayyeh, A., Victor, D., Saharia, A., McMillan, R., Al Najjar, E., Bugazia, D., Al-Rawi, M., & Ghobrial, R. M. (2022). Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series. Current Oncology, 29(5), 3585-3594. https://doi.org/10.3390/curroncol29050290